1
|
Lok AS and McMahon BJ: Chronic hepatitis
B: update 2009. Hepatology. 50:661–662. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lavanchy D: Hepatitis B virus
epidemiology, disease burden, treatment, and current and emerging
prevention and control measures. J Viral Hepat. 11:97–107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Colacino JM and Staschke KA: The
identification and development of antiviral agents for the
treatment of chronic hepatitis B virus infection. Prog Drug Res.
50:259–322. 1998. View Article : Google Scholar : PubMed/NCBI
|
4
|
Li SY, Qin L, Zhang L, et al: Molecular
epidemical characteristics of Lamivudine resistance mutations of
HBV in southern China. Med Sci Monit. 17:PH75–PH80. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
European Association For The Study Of The
Liver. EASL Clinical Practice Guidelines: management of chronic
hepatitis B. J Hepatol. 50:227–242. 2009. View Article : Google Scholar
|
6
|
Sayan M, Akhan SC and Senturk O: Frequency
and mutation patterns of resistance in patients with chronic
hepatitis B infection treated with nucleos(t)ide analogs in add-on
and switch strategies. Hepat Mon. 11:835–842. 2011.
|
7
|
Nguyen MH and Keeffe EB: Chronic hepatitis
B: early viral suppression and long-term outcomes of therapy with
oral nucleos(t)ides. J Viral Hepat. 16:149–155. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Deng L and Tang H: Hepatitis B virus drug
resistance to current nucleos(t)ide analogs: Mechanisms and
mutation sites. Hepatol Res. 41:1017–1024. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Sheldon J, Rodès B, Zoulim F,
Bartholomeusz A and Soriano V: Mutations affecting the replication
capacity of the hepatitis B virus. J Viral Hepat. 13:427–434. 2006.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Josefson D: Oral treatment for hepatitis B
gets approval in the United States. BMJ. 317:10341998. View Article : Google Scholar : PubMed/NCBI
|
11
|
Bartholomeusz A and Locarnini SA:
Antiviral drug resistance: clinical consequences and molecular
aspects. Semin Liver Dis. 26:162–170. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Pontisso P, Poon MC, Tiollais P and
Brechot C: Detection of hepatitis B virus DNA in mononuclear blood
cells. Br Med J (Clin Res Ed). 288:1563–1566. 1984. View Article : Google Scholar
|
13
|
Liu MC, Wang GQ, Piao WH, et al: Detection
of hepatitis B virus covalently closed circular DNA in peripheral
blood mononuclear cells from patients with chronic hepatitis B
infection. Zhonghua Gan Zang Bing Za Zhi. 12:249–250. 2004.(In
Chinese). PubMed/NCBI
|
14
|
Ke CZ, Chen Y, Gong ZJ, et al: Dynamic
changes of HBV DNA in serum and peripheral blood mononuclear cells
of chronic hepatitis patients after lamivudine treatment. World J
Gastroenterol. 12:4061–4063. 2006.PubMed/NCBI
|
15
|
Lu L, Zhang HY, Yueng YH, et al:
Intracellular levels of hepatitis B virus DNA and pregenomic RNA in
peripheral blood mononuclear cells of chronically infected
patients. J Viral Hepat. 16:104–112. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Hamidi-Fard M, Makvandi M, Samarbaf-Zadeh
A, et al: Mutation analysis of hepatitis B virus reverse
transcriptase region among untreated chronically infected patients
in Ahvaz city (South-West of Iran). Indian J Med Microbiol.
31:360–365. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Murakami Y, Minami M, Daimon Y and Okanoue
T: Hepatitis B virus DNA in liver, serum, and peripheral blood
mononuclear cells after the clearance of serum hepatitis B virus
surface antigen. J Med Virol. 72:203–214. 2004. View Article : Google Scholar
|
18
|
Mason A, Wick M, White H and Perrillo R:
Hepatitis B virus replication in diverse cell types during chronic
hepatitis B virus infection. Hepatology. 18:781–789. 1993.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Pontisso P, Morsica G, Ruvoletto MG, et
al: Hepatitis B virus binds to peripheral blood mononuclear cells
via the pre S1 protein. J Hepatol. 12:203–206. 1991. View Article : Google Scholar : PubMed/NCBI
|
20
|
Coffin CS, Mulrooney-Cousins PM, Peters
MG, et al: Molecular characterization of intrahepatic and
extrahepatic hepatitis B virus (HBV) reservoirs in patients on
suppressive antiviral therapy. J Viral Hepat. 18:415–423. 2011.
View Article : Google Scholar
|
21
|
Neumann-Fraune M, Beggel B, et al: High
frequency of complex mutational patterns in lamivudine resistant
hepatitis B virus isolates. J Med Virol. 85:775–779. 2013.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang Z, Huang Y, Wen S, Zhou B and Hou J:
Hepatitis B virus genotypes and subgenotypes in China. Hepatol Res.
37:S36–S41. 2007. View Article : Google Scholar : PubMed/NCBI
|
23
|
Pujol FH, Navas MC, Hainaut P and Chemin
I: Worldwide genetic diversity of HBV genotypes and risk of
hepatocellular carcinoma. Cancer Lett. 286:80–88. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kao JH, Chen PJ, Lai MY and Chen DS:
Hepatitis B genotypes correlate with clinical outcomes in patients
with chronic hepatitis B. Gastroenterology. 118:554–559. 2000.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Michalak TI, Pasquinelli C, Guilhot S and
Chisari FV: Hepatitis B virus persistence after recovery from acute
viral hepatitis. J Clin Invest. 94:9071994. View Article : Google Scholar : PubMed/NCBI
|
26
|
Rehermann B, Ferrari C, Pasquinelli C and
Chisari FV: The hepatitis B virus persists for decades after
patients’ recovery from acute viral hepatitis despite active
maintenance of a cytotoxic T-lymphocyte response. Nat Med.
2:1104–1108. 1996. View Article : Google Scholar : PubMed/NCBI
|
27
|
Cabrerizo M, Bartolomé J, Caramelo C,
Barril G and Carreno V: Molecular analysis of hepatitis B virus DNA
in serum and peripheral blood mononuclear cells from hepatitis B
surface antigen-negative cases. Hepatology. 32:116–123. 2000.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Pallier C, Castéra L, Soulier A, et al:
Dynamics of hepatitis B virus resistance to lamivudine. J Virol.
80:643–653. 2006. View Article : Google Scholar :
|
29
|
Xiong X, Yang H, Westland CE, Zou R and
Gibbs CS: In vitro evaluation of hepatitis B virus polymerase
mutations associated with famciclovir resistance. Hepatology.
31:219–224. 2000. View Article : Google Scholar
|